CD74 and neoplasm: In three cases (Figure 2F, #15, #21 and #27), we found no CD74 immunoreactivity in tumor cells with UMAb231 (Figure 2F; panel b), but weak to moderate reactivity with LN-2 (Figure 2F; panel a, black arrow).